Expert guidance on classifying adverse vs. nonadverse nerve fiber degeneration in intrathecal oligonucleotide nonclinical toxicity studies.
Expert guidance on classifying adverse vs. nonadverse nerve fiber degeneration in intrathecal oligonucleotide nonclinical toxicity studies.
Explore how early integration of toxicologic pathology can improve medical device safety, reduce miscommunication, and strengthen regulatory outcomes in device development.
Learn how integrating toxicologic pathology best practices into medical device evaluation can improve biological assessment, strengthen regulatory outcomes, and reduce study risk.
StageBio Director of Digital and Quantitative Pathology Thomas Lemarchand, DMV, DESV-AP, PhD, DECVP, recently co-authored a study that successfully demonstrated the effectiveness of a highly standardized porcine model for assessing dermal and epidermal wound healing.
Good Laboratory Practices (GLP) refers to a system where non-clinical health and safety studies are carried out, planned, monitored, recorded, archived and reported.
Date: Sept 13-16
Location: Vienna, Austria
Date: Oct 27-30
Location: Hamburg, Germany